To evaluate the mRNA expression ratio of Bcl-2/Bax both in normal and tumoralbladder tissues of patients with transitional cell carcinoma (TCC) of bladder andinvestigate potential correlation between this expression ratio and clinical outcome. The gene discussed is BAX; the disease is transitional cell carcinoma.